A study of hepcidin and monocyte chemoattractant protein-1 in egyptian females with systemic lupus erythematosus

Journal of Clinical Laboratory Analysis

Volumn 28, Issue 4, 2014, Pages 306-309

  Mohammed, Moataz Fatthy ^a   Belal, Dawlat ^a   Bakry, Seham ^a   Marie, Mohamed A ^a   Rashed, Laila ^b   Eldin, Reham Emad ^a   Abd Elhamid, Samah Mohamed ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Hepcidin; Lupus nephritis; Monocyte chemoattractant protein 1; Urinary biomarkers

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CREATININE; DOUBLE STRANDED DNA; HEPCIDIN; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; EGYPT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INFLAMMATION; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; PROTEIN URINE LEVEL; SYSTEMIC LUPUS ERYTHEMATOSUS; MIDDLE AGED; URINE; YOUNG ADULT;

ADOLESCENT; ADULT; CHEMOKINE CCL2; EGYPT; FEMALE; HEPCIDINS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; YOUNG ADULT;

EID: 84904087780     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.21685     Document Type: Article

References (14)

1. Mok CC. Prognostic factors in lupus nephritis. Lupus 2005;14(1):39-44.
2. Mok CC. Update on emerging drug therapies for systemic lupus erythematosus. Expert Opin Emerg Drugs 2010;15:53-70.
3. Rovin BH, Birmingham DJ, Nagaraja HN, Yu CY, Hebert LA. Biomarker discovery inhuman SLE nephritis. Bull NYU Hosp Jt Dis 2007;65(3):187-193.
4. Nemeth E, Valore EV, Territo M, et al. Hepcidin, aputative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 2003;101(7):2461-2463.
5. Gillespie E. Interferon-regulated biomarkers of disease activity in SLE. Lupus 2010;19:1.
6. Weening JJ, D'Agati VD, Schwartz MM, et al. Classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004;65: 521-530.
7. Binder E, Edelbauer M. Use of biomarkers in the management of children with lupus. Curr Rheumatol Rep 2013;15(3):312.
8. Zhang X, Jin M, Wu H, et al. Biomarkers of lupus nephritis determined by serial urine proteomics. Kidney Int 2008;74(6):799-807.
9. Singh RG, Usha FR, Rathore SS, Behura SK, Singh NK. Urinary MCP-1 as diagnostic and prognostic marker in patients with lupus nephritis flare. Lupus 2012;21(11):1214-1218.
10. Kiani AN, Johnson K, Chen C, et al. Urine osteoprotegerin and monocyte chemoattractant protein-1 in lupus nephritis. J Rheumatol 2009;36(10):2224-2230.
11. Marks SD, Shah V, Pilkington C, Tullus K. Urinary monocyte chemoattractant protein-1 correlates with disease activity in lupus nephritis. Pediatr Nephrol 2010;25(11):2283-2288.
12. Rosa RF, Takei K, Araújo NC, Loduca SM, Szajubok JC, Chahade WH. Monocyte chemoattractant-1 as a urinary biomarker for the diagnosis of activity of lupus nephritis in Brazilian patients. J Rheumatol 2012;39(10):1948-1954.
13. Zhang X, Rovin BH. Hepcidin expression by human monocytes in response to adhesion and pro-inflammatory cytokines. Biochim Biophys Acta 2010;12:1262-1267.
14. Brunner HI, Bennett MR, Mina R, et al. Association of noninvasively measured renal protein biomarkers with histologic features of lupus nephritis. Arthritis Rheum 2012;64(8):2687-2697.